Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial

被引：32

作者：

Tokumasu, M. ^{[1
]}

Murata, C. ^{[2
]}

Shimada, A. ^{[3
]}

Ohki, K. ^{[2
]}

Hayashi, Y. ^{[2
]}

Saito, A. M. ^{[4
]}

Fujimoto, J. ^{[5
]}

Horibe, K. ^{[4
]}

Nagao, M. ^{[6
]}

Itoh, H. ^{[6
]}

Kamikubo, Y. ^{[6
]}

Nakayama, H. ^{[7
]}

Kinoshita, A. ^{[8
]}

Tomizawa, D. ^{[9
]}

Taga, T. ^{[10
]}

Tawa, A. ^{[11
]}

Tanaka, S. ^{[12
]}

Heike, T. ^{[1
]}

Adachi, S. ^{[6
]}

机构：

[1] Kyoto Univ, Dept Pediat, Kyoto, Japan

[2] Gunma Childrens Med Ctr, Dept Hematol Oncol, Shibukawa, Japan

[3] Okayama Univ, Dept Pediat, Okayama, Japan

[4] Natl Hosp Org, Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan

[5] Natl Ctr Child Hlth & Dev, Clin Res Ctr, Tokyo, Japan

[6] Kyoto Univ, Human Hlth Sci, Kyoto, Japan

[7] Natl Hosp Org, Fukuoka Higashi Med Ctr, Dept Pediat, Koga, Japan

[8] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan

[9] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Tokyo, Japan

[10] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga 52021, Japan

[11] Natl Hosp Org, Osaka Med Ctr, Dept Pediat, Osaka, Japan

[12] Kyoto Univ, Dept Pharmacoepidemiol, Kyoto, Japan

来源：

LEUKEMIA | 2015年 / 29卷 / 12期

关键词：

ACUTE MYELOID-LEUKEMIA; GENETIC LESIONS; RELAPSE; FLT3; RAS;

D O I：

10.1038/leu.2015.121

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2438 / 2441

页数：5

共 50 条

[21] Double CEBPA Mutations Are Not Associated With Favorable Clinical Outcome In Pediatric AML: A Report From The Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)
Matsuo, Hidemasa
Kajihara, Mio
Tomizawa, Daisuke
Watanabe, Tomoyuki
Saito, Akiko Moriya
Fujimoto, Junichiro
Horibe, Keizo
Tokumasu, Mayu
Itoh, Hiroshi
Nakayama, Hideki
Kinoshita, Akitoshi
Taga, Takashi
Tawa, Akio
Taki, Tomohiko
Adachi, Souichi
BLOOD, 2013, 122 (21)
[22] Prospective Evaluation of Prognostic Relevance of KIT Mutations in Core-Binding Factor Acute Myeloid Leukemia: Results from the JALSG CBF-AML209-KIT Study
Kawashima, Naomi
Ishikawa, Yuichi
Atsuta, Yoshiko
Sugiura, Isamu
Sawa, Masashi
Dobashi, Nobuaki
Yokoyama, Hisayuki
Doki, Noriko
Tomita, Akihiro
Kiguchi, Toru
Koh, Shiro
Kanamori, Heiwa
Iriyama, Noriyoshi
Kohno, Akio
Moriuchi, Yukiyoshi
Asada, Noboru
Hirano, Daiki
Togitani, Kazuto
Sakura, Toru
Hagihara, Maki
Tomikawa, Tatsuki
Yokoyama, Yasuhisa
Asou, Norio
Ohtake, Shigeki
Matsumura, Itaru
Miyazaki, Yasushi
Naoe, Tomoki
Kiyoi, Hitoshi
BLOOD, 2018, 132
[23] Excellent outcome of risk stratified treatment for childhood acute myeloid leukemia-AML99 trial - For the Japanese Childhood AML Cooperative Study Group
Tsukimoto, I
Tawa, A
Hanada, R
Tabuchi, K
Kigasawa, H
Tsuchiya, S
Tsuchida, M
Yabe, H
Nakayama, H
Kudo, K
Kobayashi, R
Hamamoto, K
Imaizumi, M
Morimoto, A
Horibe, K
BLOOD, 2005, 106 (11) : 261A - 261A
[24] RUNX1 Mutations Have Distinct Prognostic and Clinical Implication in Pediatric AML: Results of the AML-BFM Study Group
Sendker, Stephanie
Schneider, Markus
Awada, Amani
Orhan, Eser
Sendker, Michael
Hoffmeister, Lina
Antoniou, Evangelia
Reinhardt, Dirk
Von Neuhoff, Nils
BLOOD, 2022, 140 : 9110 - 9112
[25] Refinement of the prognostic impact of somatic CEBPA bZIP domain mutations in acute myeloid leukemia: Results of the AML Study Group (AMLSG)
Ruecker, Frank G.
Corbacioglu, Andrea
Krzykalla, Julia
Cocciardi, Sibylle
Lengerke, Claudia
Germing, Ulrich
Wulf, Gerald
Samra, Maisun A.
Teichmann, Lino L.
Luebbert, Michael
Kuehn, Michael W. M.
Bentz, Martin
Westermann, Joerg
Bullinger, Lars
Gaidzik, Verena I.
Meid, Annika
Aicher, Sophia
Stegelmann, Frank
Weber, Daniela
Schrade, Anika
Thol, Felicitas
Heuser, Michael
Ganser, Arnold
Benner, Axel
Doehner, Hartmut
Doehner, Konstanze
HEMASPHERE, 2024, 8 (07):
[26] Incidence and Prognostic Relevance of ASXL2 Mutations in Adult CBF-AML with t(8;21)(q22; q22): A Study of the German-Austrian AML Study Group (AMLSG)
Jahn, Nikolaus
Agrawal, Mridul
Bullinger, Lars
Weber, Daniela
Corbacioglu, Andrea
Gaidzik, Verena I.
Thol, Felicitas
Heuser, Michael
Krauter, Juergen
Goehring, Gudrun
Kuendgen, Andrea
Fiedler, Walter
Wattad, Mohammad Amen
Held, Gerhard
Kraemer, Doris
Horst, Heinz A.
Luebbert, Michael
Ganser, Arnold
Schlenk, Richard F.
Dohner, Hartmut
Dohner, Konstanze
Paschka, Peter
BLOOD, 2015, 126 (23)
[27] Predisposition to prolonged neutropenia after chemotherapy for paediatric acute myeloid leukaemia is associated with better prognosis in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study
Aoki, Takahiro
Takahashi, Hiroyuki
Tanaka, Shiro
Shiba, Norio
Hasegawa, Daiichiro
Iwamoto, Shotaro
Terui, Kiminori
Moritake, Hiroshi
Nakayama, Hideki
Shimada, Akira
Koh, Katsuyoshi
Goto, Hiroaki
Kosaka, Yoshiyuki
Saito, Akiko M.
Horibe, Keizo
Kinoshita, Akitoshi
Tawa, Akio
Taga, Takashi
Adachi, Souichi
Tomizawa, Daisuke
BRITISH JOURNAL OF HAEMATOLOGY, 2021, 193 (01) : 176 - 180
[28] Outcome of relapsed core binding factor acute myeloid leukemia in children: A result from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05R study
Moritake, Hiroshi
Tanaka, Shiro
Nakayama, Hideki
Miyamura, Takako
Iwamoto, Shotaro
Shimada, Akira
Terui, Kiminori
Saito, Akiko
Shiba, Norio
Hayashi, Yasuhide
Tomizawa, Daisuke
Taga, Takashi
Goto, Hiroaki
Hasegawa, Daisuke
Horibe, Keizo
Mizutani, Shuki
Adachi, Souichi
PEDIATRIC BLOOD & CANCER, 2017, 64 (10)
[29] Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group
H Matsuo
M Kajihara
D Tomizawa
T Watanabe
A M Saito
J Fujimoto
K Horibe
K Kodama
M Tokumasu
H Itoh
H Nakayama
A Kinoshita
T Taga
A Tawa
T Taki
S Tanaka
S Adachi
Blood Cancer Journal, 2014, 4 : e226 - e226
[30] Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group
Matsuo, H.
Kajihara, M.
Tomizawa, D.
Watanabe, T.
Saito, A. M.
Fujimoto, J.
Horibe, K.
Kodama, K.
Tokumasu, M.
Itoh, H.
Nakayama, H.
Kinoshita, A.
Taga, T.
Tawa, A.
Taki, T.
Tanaka, S.
Adachi, S.
BLOOD CANCER JOURNAL, 2014, 4 : e226 - e226

← 1 2 3 4 5 →